Drug-induced death of leukaemic cells after G2/M arrest: Higher order DNA fragmentation as an indicator of mechanism

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 40-50

  Sleiman, R J ^a   Catchpoole, D R ^a,b   Stewart, B W ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

50 kb DNA breakage; Apoptosis; Etoposide; G2 M arrest; Leukaemia

Indexed keywords

DNA FRAGMENT; ETOPOSIDE;

ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; DNA CLEAVAGE; DNA STRAND BREAKAGE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

EID: 0031964248     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.7     Document Type: Article

References (72)

1. Allen PD, Bustin SA and Newland AC (1993) The role of apoptosis (programmed cell death) in hemopoiesis and the immune system. Blood 7: 63-73
2. An B and Dou QP (1996) Cleavage of retinoblastoma protein during apoptosis: An interleukin 1β-converting enzyme-like protease as candidate. Cancer Res 56: 438-442
3. Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD and Raff MC (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70: 31-46
4. 1+ and pH. Biochem Biophys Res Commun 186: 782-789
5. Barry MA, Behnke CA and Eastman A (1990) Activition of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362
6. Beere HM, Chresta CM, Alejo-Hergerg A, Skladanowski A, Dive C, Larsen AK and Hickman JA (1995) Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmacol 47: 986-996
7. Bertrand R, Sarange M, Jenkin J, Kerrigan D and Pommier Y (1991) Differential induction of secondary DNA fragmentation by topoisomerase II inhibitors in human tumor cell lines with amplified c-myc expression. Cancer Res 51: 6280-6285
8. Bonelli G, Sacchi MC, Barbiero G, Duranti F, Goglio G, Verdun di Cantogno L, Amenta JS, Piacentini M, Tacchetti C and Baccino FM (1996) Apoptosis of L929 cells by etoposide: A quantitative and kinetic approach. Exp Cell Res 228: 292-305
9. Bordow SB, Haber M, Madafiglio J, Cheung B, Marshall GM and Norris MD (1994) Expression of the multidrug resistance-associated protein (MRP) is correlated with amplification and over-expression of the N-myc oncogene in primary human neuroblastoma and cell lines. Cancer Res 54: 5036-5040
10. Bortner CD, Oldenburg NBE and Cidlowski JA (1995) The role of DNA fragmentation in apoptosis. Trends Cell Biol 5: 21-26
11. Brown DG, Sun X-M and Cohen GM (1993) Dexamethasone-induced apoptosis invokes cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 268: 3037-3039
12. Campana D and Janossy G (1988) Proliferation of normal and malignant human immature lymphoid cells. Blood 71: 1201-1210
13. Catchpoole DR and Stewart BW (1993) Etoposide-induced cytotoxicity in two human T-cell leukemic lines: Delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res 53: 4287-4296
14. Catchpoole DR and Stewart BW (1995) Formation of apoptotic bodies is associated with internucleosomal DNA fragmentation during drug-induced apoptosis. Exp Cell Res 215: 169-177
15. Chang WP and Little JB (1991) Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int J Radiat Biol 60: 483-496
16. Watl/Cip1with PCNA. Ocogene 11: 1931-1937
17. Chomczynski P and Sacchi N (1987) Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159
18. Chow K-C and Ross WE (1987) Topoisomerase-specific drug sensitivity in relation to cell cycle progression. Mol Cell Biol 7: 3119-3123
19. Cohen GM, Sun XM, Fearnhead H, MacFarlane M, Brown DG, Snowden RT and Dinsdale D (1994) Formation of large molecular weight fragments of DNA is a key committed step of apoptosis in thymocytes. J Immunol 153: 507-516
20. Compton MM (1992) A biological hallmark of apoptosis: Internucleosomal degradation of the genome. Cancer Metastas Rev 11: 105-119
21. Constantinou A, Grdina D, Kiguchi K and Huberman E (1992) The effect of topoisomerase inhibitors on the expression of differentiation markers and cell cycle progression in human K562 leukemia cells. Exp Cell Res 203: 100-106
22. da Silva CP, de Oliveira CR and de Lima AP (1996) Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukaemic T-lymphocytes. Biochem Pharmocol 51: 1331-1340
23. Deitch AD, Law H and White RD (1982) A stable propidium iodide staining procedure for flow cytometry. J Histochem Cytochem 30: 967-972
24. Del Bino G, Skierski JS and Darzynkiewicz Z (1991) The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195: 485-491
25. Demarcq C, Bunch RT, Creswell D and Eastman A (1994) The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Diff 5: 983-993
26. Desjardins LM and MacManus JP (1995) An adherent cell model to study different stages of apoptosis. Exp Cell Res 216: 380-387
27. 1 arrest and apoptosis. Proc Natl Acad Sci USA 92: 9019-9023
28. Eliopoulos AG, Kerr DJ, Herod J, Hodgkins L, Krajewski S, Reed JC and Young LS (1995) The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and bcl-2. Oncogene 11: 1217-1228
29. Falcieri E, Martelli AM, Bareggi R, Cataldi A and Cocco L (1993) The protein kinase inhibitor staurosporine induces morphological changes typical of apoptosis in MOLT-4 cells without concomitant DNA fragmentation. Biochem Biophys Res Commun 193: 19-25
30. Filipski I, Leblanc J, Youdale T, Sikorska M and Walker PR (1990) Periodicity of DNA folding in higher order chromatin structures. EMBO J 9: 1319-1327
31. Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J and Jarvis WD (1996) Effect of 1-β-D-arabinofuranosylcytosine on apoptosis and differentiation on human monocytic leukaemia cells (U937) expressing a c-jun dominant-negative mutant protein (TAM67). Cell Growth Diff 7: 603
32. Hickman JA (1992) Apoptosis induced by anticancer drugs. Cancer Metast Rev 11: 121-139
33. Hotz MA, Del Bino G, Lassota P, Traganos F and Darzynkiewcz Z (1992) Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. Cancer Res 52: 1530-1535
34. Jordon MA, Wendell K, Gardiner S, Derry WB, Copp H and Wilson L (1996) Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res 56: 816-825
35. Lazebnik YA, Takahashi A, Moir RD, Goldman RD, Poirier GG, Kaufmann SH and Earnshaw WC (1995) Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA 92: 9042-9046
36. Lennon SV, Martin SJ and Cotler TG (1991) Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif 24: 203-214
37. Li CJ, Wang C and Pardee AB (1995) Induction of apoptosis by β-lapachone in human prostate cancer cells. Cancer Res 55: 3712-3715
38. Lock RB and Stribinskiene L (1996) Dual modes of death induced by etoposide in human epithelial tumour cells allow bcl-2 to inhibit apoptosis without affecting clonogenic survival. Cancer Res 56: 4006-4012
39. Lock RB, Galperina OV, Feldhoff RC and Rhodes LJ (1994) Concentration-dependent differences in the mechanisms by which caffeine potentiates etoposide cytotoxicity in HeLa cells. Cancer Res 54: 4933-4939
40. Lowe SW, Schmitt EM, Smith SW, Osborne BA and Jacks T (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849
41. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE and Jacks T (1994) P53 status and the efficacy of cancer therapy in vivo. Science 266: 807-810
42. Ma DDF, Sylwestrowicz T, Janossy G and Hoffbrand AV (1983) The role of purine metabolic enzymes and terminal deoxynucleotidyl tranferase in intrathymic T-cell differentiation. Immunol Today 4: 65-68
43. Madrid-Marina V, Martinez-Valdez H and Cohen A (1990) Phorbol esters induce changes in adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyl transferase messenger RNA levels in human leukemic cell lines. Cancer Res 50: 2891-2894
44. Marks DI and Fox RM (1991) DNA damage, poly (ADP-ribosyl)ation and apoptotic cell death as a potential common pathway of cytotoxic drug action. Biochem Pharmocol 42: 1859-1867
45. Marks DI, Kurz BW, Link MP, Ng E, Shuster JJ, Lauer SJ, Brodsky I and Haines DS (1996) High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukaemia at diagnosis. Blood 87: 1155-1161
46. Martinez-Valdez H and Cohen A (1988) Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes. Proc Natl Acad Sci USA 85: 6900-6903
47. Mross KB (1996) The pharmacokinetics of epipodopyllotoxins - clinical relevance. In Acute Leukemias V: Experimental Approaches and Management of Refractory Disease. Hiddemann W, Buchner T, Wormann B, Ritter J, Creutzig U, Plunkett W and Keating M (eds), pp. 54-61. Springer: Berlin
48. Noonan KE, Beck C, Holzmayer TA, Chin JE, Wunder JS, Andrulis IL, Gazdar AF, Willman CL, Griffith B, Von Hoff DD and Roninson IB (1990) Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci USA 87: 7160-7164
49. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M (1993) Apoptotic death in epithelial cells: Cleavage of DNA to 300 and or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684
50. Oberhammer FA, Pavelka M, Sharma S, Tiefenbacher R, Purchio AF, Bursch W and Schulte-Hermann R (1922) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc Natl Acad Sci USA 89: 5408-5412
51. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S and Igarashi Y (1995) Induction of apoptosis by sphingosine in human-leukemic HL-60 cells: A possible endogenous modulator of apoptosis DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 55: 691-697
52. Ormerod MG, Orr RM and Peacock JH (1994) The role of apoptosis in cell killing by cisplatin: A flow cytometric study. Br J Cancer 69: 93-100
53. 2-arrest in Chinese hamster ovary cells treated with anticancer drugs. J Natl Cancer Inst 57: 1139-1143
54. Rusch V, Klimstra D, Venkatraman E, Oliver J, Martini N, Gralla R, Kris M and Dmitrovsky E (1995) Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced non-small cell lung cancer. Cancer Res 55: 5038-5042
55. Sachs L and Lotem J (1993) Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82: 15-21
56. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA and Akbar AN (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24: 892-899
57. Schimke RT, Kung A, Sherwood SS, Sheridan J and Sharma R (1995) Life, death and genomic change in perturbed cell cycles. In The Role of Apoptosis in Development, Tissue Homeostasis and Malignancy: Death from Inside Out. Dexter TM, Raff MC and Wyllie AH (eds), pp. 75-81. Chapman & Hall: London
58. Schwartz PM, Barnett SK, Atillasoy ES and Milstone LM (1992) Methotrexate induces differentiation of human keratinocytes. Proc Natl Acad Sci USA 89: 594-598
59. Smith GK, Duch DS, Dev IK and Kaufmann SH (1992) Metabolic effects and kill of human T-cell leukemia by 5-deazaacyclotetrahydrofolate, a specific inhibitor of glycineamide ribonucleotide transformylase. Cancer Res 52: 4895-4903
60. Sorenson CM, Barry MA and Eastman A (1990) Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755
61. Stewart BW (1994) Mechanisms of apoptosis: Integration of genetic, biochemical and cellular indicators. J Natl Cancer Inst 86: 1286-1296
62. Stewart BW, Sleiman RJ and Catchpoole DR (1995) Relationships between cell cycle distribution, differentiation and apoptosis in etoposide-treated human leukemic cells (abstract). Proc Am Assoc Cancer Res 36: 19
63. 2+-dependent cleavage of DNA into kilobase pair fragments is responsible for the initial degradation of DNA in apoptosis. J Biol Chem 269: 14857-14860
64. Tornaletti S and Pfeifer GP (1995) Complete and tissue-independent methylation of CpG sites in the p53 gene: Implications for mutations in human cancer. Oncogene 10: 1493-1499
65. Touneki O, Pron G, Belebradek J Jr and Mir LM (1993) Bleomycin, an apoptosismimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53: 5462-5469
66. Vaux DL and Strasser A (1996) The molecular biology of apoptosis. Proc Natl Acad Sci USA 93: 2239-2244
67. Walker PR, Weaver VM, Lach B, Leblanc J and Sikorska M (1994) Endonuclease activities associated with high molecular weight and internucleosomal DNA fragmentation in apoptosis. Exp Cell Res 213: 100-106
68. Warrell RP (1997) Differiation Agents. In Cancer: Principles and Practice of Oncology. 5th edn. DeVita VT, Hellman S and Rosenberg SA (eds), pp. 483-490. Lippincott-Raven: Philadelphia
69. Watanabe H, Kanbe K, Shinozaki T, Hoshino H and Chigira M (1995) Apoptosis of a fibrosarcoma induced by protein-free culture involves DNA cleavage to large fragments but not internucleosomal fragmentation. Int J Cancer 62: 191-198
70. Weis M, Schlegel J, Kass GEN, Holmstrom TH, Peters I, Eriksson J, Orrenius S and Chow SC (1995) Cellular events in Fas/APO-1-mediated apoptosis in JURKAT T lymphocytes. Exp Cell Res 219: 699-708
71. Wyllie AH (1987) Apoptosis: Cell death in tissue regulation. J Pathol 153: 313-316
72. Zhivotovsky B, Wade D, Gahm A, Orrenius S and Nicotera P (1994) Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation. FEBS Lett 351: 150-154